🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "specific steps to deal with cost of living challenges" in the forthcoming Budget.

During an interview with media outlets, she noted that reducing inflation is a joint duty of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Possible Energy Bill Measures

Sources suggest the administration could take action to lower utility costs, for example by cutting the present 5% rate of value-added tax charged on energy.

A further possibility is to cut some of the regulatory levies currently added to bills.

Budgetary Limitations and Expert Expectations

The administration will receive the latest draft from the official forecaster, the OBR, on Monday, which will reveal how much space there is for these actions.

The view from most experts is that Reeves will have to announce higher taxes or spending cuts in order to fulfill her declared debt limits.

Previously on the same day, analysis showed there was a £22 billion deficit for the chancellor to fill, which is at the lower end of forecasts.

"It is a collective task between the central bank and the administration to continue tackling some of the sources of price increases," Reeves stated to reporters in Washington, at the conferences of the IMF and World Bank.

Revenue Commitments and International Concerns

While a great deal of the focus has been on likely tax rises, the chancellor said the most recent information from the OBR had not changed her pledge to campaign commitments not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with increasing geopolitical and commercial tensions for the fiscal revenue measures, likely to be targeted on those "wealthiest."

Global Economic Disputes

Commenting on apprehensions about the United Kingdom's commercial links with the Asian nation she said: "Our national security invariably come first."

Last week's statement by China to tighten export controls on rare earths and other resources that are essential for advanced tech manufacturing led American leader Donald Trump to suggest an further 100% tariff on imports from the Asian country, raising the risk of an full-scale trade war between the two largest economies.

The American finance chief described the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on considering the US offer to participate in its conflict with China, the Chancellor said she was "very concerned" by China's actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the decision was "bad for the world economy and causes additional challenges."

"In my view there are fields where we need to address Chinese policies, but there are also significant opportunities to export to China's economy, including financial services and other areas of the economic system. We've got to maintain that balance right."

The Treasury chief also affirmed she was cooperating with G7 counterparts "on our own essential resources plan, so that we are reduced dependence."

NHS Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service spends on medicines could go up as a consequence of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said in recent statements that they are either halting or canceling projects in the UK, with several attributing the modest returns they are obtaining.

Last month, the Science Minister said the price the health service pays for medicines would have to increase to prevent businesses and pharmaceutical investment departing from the UK.

Reeves informed the BBC: "We have seen as a result of the pricing regime, that medical research, innovative medicines have not been available in the United Kingdom in the extent that they are in other European countries."

"Our aim is to guarantee that people receiving care from the NHS are can access the best essential drugs in the globe. And so we are reviewing this situation, and... seeking to secure increased investment into Britain."